Axa
IART icon

Axa’s Integra LifeSciences IART Stock Holding History

Axa’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-117,887
Closed -$1.45M – 542
2025
Q2 		$1.45M Hold
117,887
– – ﹤0.01% 825
2025
Q1 		$2.59M Buy
117,887
+8,883
+8% +$209K 0.01% 685
2024
Q4 		$2.47M Buy
109,004
+10,543
+11% +$230K 0.01% 713
2024
Q3 		$1.79M Buy
98,461
+1,772
+2% +$41.1K 0.01% 771
2024
Q2 		$2.82M Buy
96,689
+77,697
+409% +$2.3M 0.01% 677
2024
Q1 		$673K Buy
+18,992
New +$760K ﹤0.01% 902
2021
Q1 		– Sell
-52,000
Closed -$3.38M – 1266
2020
Q4 		$3.38M Hold
52,000
– – 0.01% 771
2020
Q3 		$2.46M Buy
52,000
+400
+0.8% +$19K 0.01% 776
2020
Q2 		$2.42M Buy
51,600
+17,600
+52% +$865K 0.01% 783
2020
Q1 		$1.52M Buy
+34,000
New +$1.78M 0.01% 785
2017
Q1 		– Sell
-161,900
Closed -$6.95M – 1288
2016
Q4 		$6.95M Sell
161,900
-24,440
-13% -$993K 0.03% 498
2016
Q3 		$7.69M Sell
186,340
-6,308
-3% -$264K 0.03% 476
2016
Q2 		$7.68M Buy
192,648
+80,368
+72% +$2.89M 0.03% 455
2016
Q1 		$3.78M Buy
+112,280
New +$3.5M 0.02% 628
2015
Q2 		– Sell
-27,400
Closed -$690K – 1438
2015
Q1 		$690K Sell
27,400
-111,070
-80% -$2.63M ﹤0.01% 1027
2014
Q4 		$3.07M Buy
+138,470
New +$2.81M 0.01% 686

Other funds holding IART

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Axa's IART Position: Q3 2025 in Review

Axa sold out of Integra LifeSciences (IART) in Q3 2025, closing a stake of 117,887 shares — an estimated $1.45M sold.

Axa first reported a position in IART in Q4 2014 and held it in 16 quarters. The position peaked at $7.69M in Q3 2016. 207 funds tracked by Wall St. Rank hold IART as of Q3 2025.

  • Axa reported no remaining Integra LifeSciences position as of Q3 2025 after selling out during the quarter.
  • Axa sold 117,887 Integra LifeSciences shares in Q3 2025, an estimated $1.45M.
  • Axa first reported a position in Integra LifeSciences in Q4 2014 and held it in 16 quarters.
  • Axa's Integra LifeSciences position peaked at $7.69M in Q3 2016.
  • 207 funds tracked by Wall St. Rank held Integra LifeSciences as of Q3 2025.

Based on Axa's 13F filing for Q3 2025, filed 14 Nov 2025.